In human alloreactive CD4+ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets

16Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Although kidney transplantation is the best therapy for end-stage renal disease, rejection remains a concern, and currently available immunosuppressive agents contribute to morbidity and mortality. Thus, novel immunosuppressive drugs are required. Dichloroacetate (DCA) is already used in the treatment of congenital lactic acidosis and characterized by limited toxicity. As DCA inhibits aerobic glycolysis, which is a prerequisite for CD4+ T-cell proliferation and differentiation into effector T-cells, its possible immunosuppressive role in mixed lymphocyte reaction (MLR), a model of alloreactivity, was investigated. Glucose and lactate concentrations were measured in the supernatants, and cell proliferation was assessed immunoenzymatically. CD4+ T-cells were then isolated from the MLRs and the expression of cleaved caspase-3, various enzymes involved in glycolysis, and the signature transcription factors of CD4+ T-cell subsets were evaluated by western blotting. In MLRs, DCA decreased glucose consumption and aerobic glycolysis, while it exerted a negligible effect on cell proliferation. In CD4+ T-cells, DCA induced apoptosis, and decreased the expression of glucose trasporter-1, hexokinase II, lactate dehydrogenase-A and phosphorylated pyruvate dehydrogenase, while it increased total pyruvate dehydrogenase. In addition, DCA increased the expression of transcription factor forkhead box P3, whereas it decreased the expression of T-box transcription factor TBX21, trans-acting T-cell-specific transcription factor GATA-3 and retinoic acid receptor related orphan receptor-γt. In conclusion, in alloreactive CD4+ T-cells, DCA inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset. These characteristics render it a promising immunosuppressive agent in the field of transplantation.

Cite

CITATION STYLE

APA

Eleftheriadis, T., Sounidaki, M., Pissas, G., Antoniadi, G., Liakopoulos, V., & Stefanidis, I. (2016). In human alloreactive CD4+ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets. Molecular Medicine Reports, 13(4), 3370–3376. https://doi.org/10.3892/mmr.2016.4912

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free